RU 486: How Abortion Politics Have Impacted on a Potentially Useful Drug of Broad Medical Application
Buy Issue for $25 at JHUP- RU 486:How Abortion Politics Have Impacted on a Potentially Useful Drug of Broad Medical Application
William Regelson
Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0001
References
1. BAULIEU, E.-E. RU 486 as an anti-progesterone steroid; from receptor to contragestion and beyond. JAMA 262:1808-1814, 1989.
Google Scholar
2. PALCA, J. The pill of choice: News and comments. Science 245:1319-1324, 1989.
Google Scholar
3. BAULIEU, E-E., SEGAL, S. J., eds. The Anti-Progestin Steroid RU 486 and Human Fertility Control. New York: Plenum Press, 1984.
Google Scholar
4. ULMANN, A., TEUTSCH, G. and PHILIBERT, D. RU 486. Scientific American 262:42-48, 1990.
Google Scholar
5. SILVESTRE, L., DUBOIS, C., RENNAULT, M., et al. Voluntary interruption of pregnancy with Mifepristone (RU 486) and a prostaglandin analogue. N. Engl. J. Med. 322:645-648, 1990.
Google Scholar
6. BENEDEK, E. The Dallas Morning News. p. C1, C7, 3 Dec 1990.
7. FOREMAN, J. Boston Globe, Nov. 19, 1990.
8. BROWN, C. The aborted pill. New York Woman May: 93-97, 1990.
9. WYDEN, R. U.S. House of Representatives Committee on Small Business. 19 Nov. 1990, Cong. Rec., 1991.
10. KEKKONEN, R., ALFTHAN, H., HAUKKAMAM, M., et al. Interference with ovulation by sequential treatment with the anti-progesterone RU 486 and synthetic progestin. Fertility and Sterility 53:747-750, 1990.
Google Scholar
11. REGELSON, W., LORIA, R., and KALIMI, M. Beyond abortion: RU 486 and the needs of the crisis constituency. JAMA 264:1026-1027, 1990.
Google Scholar
12. REGELSON, W. RU 486: A "pro-life" perspective. Medical Aspects of Human Sexuality 24(12):55-57, 1990.
Google Scholar
13. BERTAGNA, X., BASIN, C., PICARD, F., et al. Peripheral anti-glucocorticoid action of RU 486 in man. Clin. Endocrinol. 28:537-541, 1988.
Google Scholar
14. NIEMAN, K., CHROUSOS, G. P., KELLNER, C., et al. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J. Clin. Endocrinol. Metab. 61:536-539, 1985.
Google Scholar
15. MARKWALDER, T. M., WAELTI, E. Cited by BAULIEU, E.-E. RU 486 as an anti-progesterone steroid: From receptor to contragestion and beyond. Jama 262:1808-1814, 1989.
Google Scholar
16. GRUNBERG, S. N., WEISS, M. H., and SPITZ, I. M. Treatment of Unresectable Meningioma with the Anti-Progestational Agent RU 486. Los Angeles: University of Southern California, in press, 1991.
Google Scholar
17. BLANKENSTEIN, M. A., BLAAUW, G., and LAMBERTS, S. W. J. Progestin and estrogen receptors in human meningiomas, gliomas and brain metastasis. J. Neurooncol. 1:179-189, 1983.
Google Scholar
18. BERTAGNA, O., BERTAGNA, C., LAUDAT, M.-H., et al. Pituitary adrenal response to the anti-glucocorticoid action of RU 486 in Cushing's syndrome. J. Clin. Endocrinol. Metab. 63:639-643, 1986.
Google Scholar
19. REGELSON, W., and SINEX, M. The evidence for pituitary and thyroid control of aging: Is age reversal a myth or reality? The search for a "death hormone." In Intervention in Aging Process, Pt. B, pp. 3-52. New York: A. R. LISS, 1983.
Google Scholar
20. KERR, D. S., CAMPBELL, L. W., HAO, S. Y., et al. Corticosteroid modulation of hippocampal potentials: Increased effect with aging. Science 245:1505-1509, 1989.
Google Scholar
21. JEFFERYS, D., FUNDER, J. W. Glucocorticoids, adrenal medullary opioids and the retention of a behavioral response after stress. Endocrinol. 121:1006-1009, 1987.
Google Scholar
22. PHILLIPS, P. D., and CRISTOFALO, V. J. Classification system based on the functional equivalency of mitogens that regulate WI-38 cell proliferation. Exp. Cell Res. 175:396-403, 1988.
Google Scholar
23. TUTTON, P. I., and BARKLA, D. H. Steroid hormones as regulators of the proliferative action of normal and neoplastic epithelial cells. Anticancer Res. 8:451-456, 1988.
Google Scholar
24. LAUE, L., PEACOCK, J., BRANDON, D. D., et al. Glucocorticoid receptor mediated effects on rat...
